Skip to main content
Back to Draper Associates

Draper Associates's Therapeutics Portfolio

Browse 3 Therapeutics companies funded by Draper Associates. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
3
Total Funding in Therapeutics
$15.8M

Therapeutics Portfolio Companies (3)

Export
Artificial Intelligence (AI)BiotechnologyGenerative AIGeneticsHealth CareTherapeutics

Algen Biotechnologies is a therapeutic discovery company that builds a platform to decode functional gene networks.

San Francisco, United States
August 2021
$5.4M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalProduct ResearchTherapeutics

Syntax Bio is a biotechnology company that develops a cell programming platform to control stem cell differentiation for research.

Chicago, United States
June 2026
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife ScienceTherapeutics

HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells to extend healthy lifespan.

Los Angeles, United States
March 2026
$10.4M
Seed

Founder Contacts

30,000+ verified contacts

Explore Draper Associates's Full Portfolio

View all companies funded by Draper Associates across every industry and funding stage.

View Full Draper Associates Portfolio